\n\n\n\n\t\t\n\t\t\tCell Biosciences\n\t\t\thttp://www.cellbiosciences.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tCell Biosciences develops instrumentation and reagent systems to bring analytical chemistry to biology. Cell Biosciences is focused on breakthrough protein assay capability with our first instrument...More»
\n\t\t\tCell Biosciences develops instrumentation and reagent systems to bring analytical chemistry to biology. Cell Biosciences is focused on breakthrough protein assay capability with our first instrument platform scheduled for release within one year.
Cell Biosciences is commercializing instrumentation and reagent systems to bring analytics to biology. In the \u201cpost-genomic\u201d age, new tools are in high demand to enable researchers to rapidly develop assays for specific proteins in complex biological samples. High priority needs include specific detection of protein variants, detection of low abundance proteins in small sample volumes and improved quantification and throughput. Cell Biosciences is focused on these priorities to deliver new technology that will be enabling in these areas. We anticipate launch of our first instrument platform in 2006.«Less
Overview
\n\t\t\t\tLocation: \tPalo Alto, CA, United States\n
\n\t\t\t\tIndustry: Medical Devices & Equipment
\n\t\t\t\tTags:\n\t\t\t\tbiotech,\n\t\t\t\tbiology,\n\t\t\t\tchemistry,\n\t\t\t\tpost-genomic,\n\t\t\t\tCell,\n\t\t\t\tbiosciences\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series A - $-1M (11/22/2006)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tDomain Associates,\n\t\t\t\t\t\n\t\tLatterell Venture Partners,\n\t\t\t\t\t\n\t\tPOSCO BioVentures,\n\t\t\t\t\t\n\t\tRBC Capital Partners,\n\t\t\t\t\t\n\t\tthe Vertical Group,\n\t\t\t\t\t\n\t\tMitsui Ventures,\n\t\t\t\t\t\n\t\tNovo Nordisk\n\t\t\t\t
\n\t\t\tRecent News
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\tSep 9, 2009\n\t\t\t\t\tCell Biosciences Buys Alpha Innotech, Raises $19M\n\t\t\t\t
\n\t\t\t